These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 5984248)
1. [Problems of cytostatic treatment of sarcoma of the extremities]. Salzer M Beitr Orthop Traumatol; 1966 Dec; 13(12):800-3. PubMed ID: 5984248 [No Abstract] [Full Text] [Related]
2. [Case of metastasis following sarcoma of the epipharynx-therapy with cytostatic drugs]. Löffler P Monatsschr Ohrenheilkd Laryngorhinol; 1971; 105(3):126-9. PubMed ID: 4941965 [No Abstract] [Full Text] [Related]
3. Response of endometrial stromal sarcoma to cyclophosphamide. Hoovis ML Am J Obstet Gynecol; 1970 Dec; 108(7):1117-9. PubMed ID: 5479690 [No Abstract] [Full Text] [Related]
10. [Regional cytostatic perfusion of the extremities in patients with malignant melanoma and soft tissue sarcoma--therapeutic applications and results]. Eichfeld U; Gläser A; Schneider G; Kraus J; Pauer HJ; Schwarz I Zentralbl Chir; 1993; 118(2):63-8. PubMed ID: 7682024 [TBL] [Abstract][Full Text] [Related]
11. [Hypophysis irradiation and cytostatic aftertreatment in advanced malignant neoplasms]. Prenner K Wien Klin Wochenschr; 1966 Jul; 78(27):505-6. PubMed ID: 5995241 [No Abstract] [Full Text] [Related]
12. Management of soft tissue sarcomas of the extremity in adults. Valle AA; Kraybill WG J Surg Oncol; 1996 Dec; 63(4):271-9. PubMed ID: 8982374 [TBL] [Abstract][Full Text] [Related]
14. [Isolated infusion effective in melanoma and sarcoma. Good alternative for regional isolated cytostatic perfusion]. Kroon HM; Thompson JF; Hoekstra HJ Ned Tijdschr Geneeskd; 2009 Mar; 153(11):508-14. PubMed ID: 19402327 [No Abstract] [Full Text] [Related]
15. Chemotherapy in the treatment of soft tumours. Wiltshaw E Br J Radiol; 1971 Aug; 44(524):650-1. PubMed ID: 5314755 [No Abstract] [Full Text] [Related]
16. Mcl-1 is a novel therapeutic target for human sarcoma: synergistic inhibition of human sarcoma xenotransplants by a combination of mcl-1 antisense oligonucleotides with low-dose cyclophosphamide. Thallinger C; Wolschek MF; Maierhofer H; Skvara H; Pehamberger H; Monia BP; Jansen B; Wacheck V; Selzer E Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4185-91. PubMed ID: 15217956 [TBL] [Abstract][Full Text] [Related]
17. Combination of modalities in soft tissue sarcomas. Karakousis CP Int Adv Surg Oncol; 1982; 5():91-113. PubMed ID: 6896509 [No Abstract] [Full Text] [Related]
18. Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma Group. Bramwell VH; Mouridsen HT; Santoro A; Blackledge G; Somers R; Verweij J; Dombernowsky P; Onsrud M; Thomas D; Sylvester R Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S180-4. PubMed ID: 8453694 [TBL] [Abstract][Full Text] [Related]
19. Phase II trial of trofosfamide in patients with advanced pretreated soft tissue sarcomas. Hartmann JT; Oechsle K; Mayer F; Kanz L; Bokemeyer C Anticancer Res; 2003; 23(2C):1899-901. PubMed ID: 12820475 [TBL] [Abstract][Full Text] [Related]